Glioblastoma Multiforme in the Elderly: A Therapeutic Challenge

被引：0
|
作者：
A. Mangiola
G. Maira
P. De Bonis
M. Porso
B. Pettorini
G. Sabatino
C. Anile
机构：
[1] Catholic University School of Medicine,Institute of Neurosurgery
[2] Catholic University School of Medicine,Institute of Geriatrics
来源：
Journal of Neuro-Oncology | 2006年 / 76卷
关键词：
adjuvant therapy; elderly; glioblastoma multiforme; prognosis; radioimmunotherapy; surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Introduction: Elderly patients with glioblastoma multiforme (GBM) are frequently excluded from cancer therapy trials, treated suboptimally or not treated at all. The average survival in elderly patients is 4–8 months. The goal of the present study was to evaluate the efficacy of different treatment options in terms of survival in an elderly population affected with GBM.
引用
收藏
页码：159 / 163
页数：4
相关论文
共 50 条
  • [41] Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme
    Manciu, Felicia S.
    Guerrero, Jose
    Bennet, Kevin E.
    Chang, Su-Youne
    Rahman, Masum
    Lopez, Lizbeth V. Martinez
    Chantigian, Siobhan
    Castellanos, Mariana
    Manciu, Marian
    SENSORS, 2022, 22 (07)
  • [42] Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
    Antonela Sofía Asad
    Alejandro Javier Nicola Candia
    Nazareno Gonzalez
    Camila Florencia Zuccato
    Araceli Abt
    Santiago Jordi Orrillo
    Yael Lastra
    Emilio De Simone
    Florence Boutillon
    Vincent Goffin
    Adriana Seilicovich
    Daniel Alberto Pisera
    María Jimena Ferraris
    Marianela Candolfi
    Scientific Reports, 9
  • [43] Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
    Khabibov, Marsel
    Garifullin, Airat
    Boumber, Yanis
    Khaddour, Karam
    Fernandez, Manuel
    Khamitov, Firat
    Khalikova, Larisa
    Kuznetsova, Natalia
    Kit, Oleg
    Kharin, Leonid
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 60 (06)
  • [44] Recent therapeutic advances and insights of recurrent glioblastoma multiforme
    Chen, Juxiang
    Xu, Tao
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 676 - 684
  • [45] Molecular pathways and potential therapeutic targets in glioblastoma multiforme
    Wardak, Zabi
    Choe, Kevin S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (11) : 1307 - 1318
  • [46] Current Therapeutic Alternatives and New Perspectives in Glioblastoma Multiforme
    Arevalo, Angelo S. T.
    Erices, Jose I.
    Uribe, Daniel A.
    Howden, Jake
    Niechi, Ignacio
    Munoz, Sebastian
    Martin, Rody S.
    Monras, Claudia A. Q.
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (25) : 2781 - 2795
  • [47] Therapeutic cell-based vaccines for glioblastoma multiforme
    Pour, Mehrshad Ebrahim
    Moghadam, Samin Ghorbani
    Shirkhani, Parian
    Sahebkar, Amirhossein
    Mosaffa, Fatemeh
    MEDICAL ONCOLOGY, 2023, 40 (12)
  • [48] MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
    Knubel, Kristina H.
    Pernu, Ben M.
    Sufit, Alexandra
    Nelson, Sarah
    Pierce, Angela M.
    Keating, Amy K.
    ONCOTARGET, 2014, 5 (05) : 1338 - 1351
  • [49] Glioblastoma Multiforme - a Review of Pathogenesis, Biomarkers and Therapeutic Perspectives
    Polivka, J.
    Polivka, J., Jr.
    Rohan, V.
    Topolcan, O.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 (05) : 575 - 583
  • [50] Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
    Sofia Asad, Antonela
    Nicola Candia, Alejandro Javier
    Gonzalez, Nazareno
    Florencia Zuccato, Camila
    Abt, Araceli
    Jordi Orrillo, Santiago
    Lastra, Yael
    De Simone, Emilio
    Boutillon, Florence
    Goffin, Vincent
    Seilicovich, Adriana
    Alberto Pisera, Daniel
    Jimena Ferraris, Maria
    Candolfi, Marianela
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345